BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24767333)

  • 1. Successful active immunization using a hepatitis B virus vaccination protocol for a recipient with hepatitis B core antibody-positive liver graft.
    Ohno Y; Mita A; Ikegami T; Masuda Y; Urata K; Nakazawa Y; Kobayashi A; Miyagawa S
    Transplant Proc; 2014 Apr; 46(3):721-5. PubMed ID: 24767333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of active immunization in the prevention of de novo hepatitis B virus infection after pediatric liver transplantation with HBcAb positive donor liver].
    Cui Y; Lu W; Gao W; Dong C; Han C; Liu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Oct; 29(10):926-930. PubMed ID: 29017655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
    Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
    Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active immunization against de novo hepatitis B virus infection in pediatric patients after liver transplantation.
    Chang SH; Suh KS; Yi NJ; Choi SH; Lee HJ; Seo JK; Lee KU
    Hepatology; 2003 Jun; 37(6):1329-34. PubMed ID: 12774011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
    Lee S; Kim JM; Choi GS; Park JB; Kwon CH; Choe YH; Joh JW; Lee SK
    Liver Transpl; 2016 Feb; 22(2):247-51. PubMed ID: 26600319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation.
    Lee KW; Lee DS; Lee HH; Kim SJ; Joh JW; Seo JM; Choe YH; Lee SK
    Transplant Proc; 2004 Oct; 36(8):2311-2. PubMed ID: 15561233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
    Holt D; Thomas R; Van Thiel D; Brems JJ
    Arch Surg; 2002 May; 137(5):572-5; discussion 575-6. PubMed ID: 11982471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.
    Skagen CL; Jou JH; Said A
    Clin Transplant; 2011; 25(3):E243-9. PubMed ID: 21323735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donors.
    Chang MS; Olsen SK; Pichardo EM; Heese S; Stiles JB; Abdelmessih R; Verna EC; Guarrera JV; Emond JC; Brown RS
    Liver Transpl; 2012 Jul; 18(7):834-8. PubMed ID: 22422699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation.
    Lin CC; Yong CC; Chen CL
    World J Gastroenterol; 2015 Oct; 21(39):11112-7. PubMed ID: 26494965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
    Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
    Veroux M; Corona D; Ekser B; Giaquinta A; Tallarita T; De Martino C; Gentile F; Virgilio C; Gagliano M; Fiamingo P; Veroux P
    Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
    Dong C; Gao W; Ma N; Sun C; Zheng WP; Wang K; Shen ZY
    Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 27933716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.
    Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Kelley M; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3187-9. PubMed ID: 16213345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe use of livers from donors with positive hepatitis B core antibody.
    Manzarbeitia C; Reich DJ; Ortiz JA; Rothstein KD; Araya VR; Munoz SJ
    Liver Transpl; 2002 Jun; 8(6):556-61. PubMed ID: 12037788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
    Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
    Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.